Figures & data
Table 1 Baseline Characteristics of Patients with Metastatic CRC According to Hypertension and HFS Status
Figure 1 Waterfall plot of best percentage change in target-lesion size among atients with previously treated metastatic colorectal cancer.
Figure 2 MRI scan results of change in target lesions in liver metastasis of one patient with metastatic colorectal cancer after treatment with regorafenib.
Figure 3 Progression-free survivaland overall survival of patients with previously treated metastatic colorectal cancer.
Table 2 Univariate PFS Analysis of Patients with Metastatic CRC According to Baseline Characteristics
Table 3 Safety Profile of Patients with Metastatic CRC Treated with Regorafenib
Figure 4 Progression-free survival of patients with previously treated metastatic colorectal cancer by hand–foot syndrome status.
Figure 5 Progression-free survival of patients with previously treated metastatic colorectal cancer by hypertension status.
Table 4 Multivariate Cox Regression Analysis of PFS According to Baseline Characteristics and Adverse-Reaction Status